comment,amr
,"# ::snt 
(a / amr-empty)"
"Vaccine efficacy: In trials, Pfizer and Moderna vaccines were over % effective. The AstraZeneca vaccine was % effective with two full doses, but % effective in a small group of trial subjects who received first a half dose, then a full dose.","# ::snt Vaccine efficacy: In trials, Pfizer and Moderna vaccines were over % effective. The AstraZeneca vaccine was % effective with two full doses, but % effective in a small group of trial subjects who received first a half dose, then a full dose.
(m / multi-sentence
      :snt1 (e / effective-04
            :ARG0 (v / vaccine
                  :mod (v2 / vaccine
                        :mod (c / company
                              :name (n / name
                                    :op1 ""Pfizer"")))
                  :mod (c2 / company
                        :name (n2 / name
                              :op1 ""Moderna"")))
            :mod (o / over
                  :op1 (p / percentage-entity))
            :snt2 (c3 / contrast-01
                  :ARG1 (e2 / effective-04
                        :ARG0 (v3 / vaccine
                              :mod (c4 / company
                                    :name (n3 / name
                                          :op1 ""AstraZeneca"")))
                        :ARG1 (d / dose-01
                              :quant 2
                              :mod (f / full)))
                  :ARG2 (e3 / effective-04
                        :ARG0 v3
                        :ARG1 (g / group
                              :mod (s / small)
                              :consist-of (s2 / subject
                                    :ARG0-of (r / receive-01
                                          :ARG1 (a / and
                                                :op1 (d2 / dose-01
                                                      :mod (h / half
                                                            :ord (o2 / ordinal-entity
                                                                  :value 1)))
                                                :op2 (d3 / dose-01
                                                      :mod (f2 / full)
                                                      :time (t / then))))))))
            :snt3 (e4 / effective-04
                  :ARG0 (v4 / vaccine
                        :mod (c5 / company
                              :name (n4 / name
                                    :op1 ""AstraZeneca"")))
                  :mod (p2 / percentage-entity
                        :value 2))
            :snt4 c3
            :ARG1 (p3 / percentage-entity
                  :value-of (e5 / effective-04
                        :ARG0 v4))
            :ARG2 (p4 / percentage-entity
                  :value-of r
                  :ARG0 g
                  :ARG1 (d4 / dose-01
                        :mod (f3 / full)))))"
"Awaiting vaccination: Vaccines can be removed from their long-term, temperature-controlled environments anytime before the six-month expiry date. But once refrigerated or in room temperature, the time of stability becomes shorter.","# ::snt Awaiting vaccination: Vaccines can be removed from their long-term, temperature-controlled environments anytime before the six-month expiry date. But once refrigerated or in room temperature, the time of stability becomes shorter.
(m / multi-sentence
      :snt1 (v / vaccinate-01
            :ARG1-of (w / wait-01))
      :snt2 (p / possible-01
            :ARG1 (r / remove-01
                  :ARG1 (v2 / vaccinate-01)
                  :ARG2 (e / environment
                        :ARG1-of (c / control-01
                              :ARG0 (t / temperature))
                        :poss v2)
                  :time (a / anytime
                        :time (b / before
                              :op1 (e2 / expire-01
                                    :ARG1 (t2 / temporal-quantity
                                          :quant 6
                                          :unit (m2 / month)))))))
      :snt3 (c2 / contrast-01
            :ARG2 (b2 / become-01
                  :ARG1 (t3 / time
                        :duration-of (s / stable-03))
                  :ARG2 (s2 / short-07
                        :ARG1 t3)
                  :time (o / or
                        :op1 (r2 / refrigerate-01
                              :ARG1 v2)
                        :op2 (t4 / temperature
                              :mod (r3 / room))))))"
"Pfizer's bespoke ultra-cold containers: Thermal shippers maintained at C using dry-ice, and GPS enabled temperature trackers help monitor vaccine stability.","# ::snt Pfizer's bespoke ultra-cold containers: Thermal shippers maintained at C using dry-ice, and GPS enabled temperature trackers help monitor vaccine stability.
(m / multi-sentence
      :snt1 (c / container
            :ARG1-of (b / bespoke-00)
            :poss (c2 / company
                  :name (n / name
                        :op1 ""Pfizer""))
            :ARG1-of (c3 / cold-01
                  :degree (u / ultra)))
      :snt2 (a / and
            :op1 (m2 / maintain-01
                  :ARG1 (s / shippers
                        :mod (t / thermal))
                  :location (t2 / temperature)
                  :manner (u2 / use-01
                        :ARG1 (ii / ice
                              :ARG1-of (d / dry-08))))
            :op2 (h / help-01
                  :ARG0 (t3 / track-01
                        :ARG1 (t4 / temperature)
                        :ARG1-of (e / enable-01
                              :ARG0 (p / product
                                    :name (n2 / name
                                          :op1 ""GPS""))))
                  :ARG1 (m3 / monitor-01
                        :ARG1 (s2 / stability
                              :mod (v / vaccine))))))"
"Source of the vaccine: Some vaccines are gambling on promising technologies, while others are relying on approaches that have proven successful in the past","# ::snt Source of the vaccine: Some vaccines are gambling on promising technologies, while others are relying on approaches that have proven successful in the past
(s / source-01
      :ARG1 (v / vaccine
            :quant (s2 / some)
            :ARG1-of (c / contrast-01
                  :ARG2 (r / rely-01
                        :ARG0 (o / other)
                        :ARG1 (a / approach-02
                              :ARG1-of (s3 / succeed-01
                                    :ARG1-of (p / prove-01
                                          :time (p2 / past)))))))
      :ARG2 (v2 / vaccine))"
